CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease

A. Santoro, S. Viviani, P. Valagussa, V. Bonfante, G. Bonadonna

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences